🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns ◆ Project Management Failures: Lessons for Healthcare ◆ FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli ◆ WeBuild Programme: 50+ Women-Led Ventures and How to Apply ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns ◆ Project Management Failures: Lessons for Healthcare ◆ FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli ◆ WeBuild Programme: 50+ Women-Led Ventures and How to Apply ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆
Clinical Trials in Australia / NCT05752032
Active, not recruiting Observational

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

NCT05752032 · tracked via the Priya Life Science Australia tracker
Sponsor
ICM Co. Ltd
Phase
Observational
Started
2023-03-16
Last updated
2026-09-03

Condition(s) studied

Osteoarthritis, Knee

Investigational drug(s) / intervention(s)

ICM-203Placebo

ICM-203: Long term follow-up

Placebo: Long term follow-up

Study summary

This is an observational study of the long term safety and efficacy of ICM-203.

Eligibility

Sex
ALL
Min age
50 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Previous receipt of ICM-203 or matching placebo Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Royal Adelaide Hospital Adelaide South Australia
Barwon Health Geelong Victoria

Other trials for the same condition

The Osteoarthritis Prevention Study Recruiting
Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Active, not recruiting
Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain Active, not recruiting
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain. Active, not recruiting
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05752032 on ClinicalTrials.gov ↗ ← All trials in Australia